Synthetic Biologics Inc.

AMEX: SYN · Real-Time Price · USD
1.02
0.01 (0.99%)
At close: Oct 13, 2022, 6:00 AM

Synthetic Biologics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a n/a n/a
Operating Income
-26.35M -21.58M -14.26M
Interest Income
697K 512K 6K
Pretax Income
-25.65M -21.11M -14.27M
Net Income
-25.65M -19.68M -14.27M
Selling & General & Admin
7.4M 9.86M 6.47M
Research & Development
12.03M 11.72M 7.8M
Other Expenses
n/a n/a n/a
Operating Expenses
19.43M 21.58M 14.27M
Interest Expense
n/a -471K 6K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
26.35M 21.58M 14.27M
Income Tax Expense
n/a -1.43M 6K
Shares Outstanding (Basic)
1.35M 15.33M 12.19M
Shares Outstanding (Diluted)
1.35M 15.33M 12.19M
EPS (Basic)
-19.03 -1.28 -1.17
EPS (Diluted)
-19.03 -1.28 -1.17
EBITDA
-26.35M -21.58M -14.17M
EBIT
n/a -21.58M -14.28M
Depreciation & Amortization
n/a 85K 87K